Equashield LLC  

Equashield® is a developer of Closed System Transfer Devices (CSTDs) for the safe handling of hazardous drugs to protect healthcare workers. Equashield's mechanically closed CSTD design relies on its unique pressure equalization behind the syringe and with its use of tight seal double membranes to keep connectors residual free despite multiple entries. Equashield® Pro is built around the Equashield CSTD and relies on its innovative design to redefine the automation workflow and optimize throughput.

Unlike traditional robot’s reliance on robotic arms that mimic human motion with use of needle and syringe leading to potential for cytotoxic drips, spills, aerosols and vapor release, Equashield® Pro uses multi-station compounding approach to minimize both the motion and time it takes to prepare a dose much like a factory manufacturing line. Equashield® Pro is also capable of processing a broad variety of finished product dosage forms and access all size drug vials to be a truly versatile machine. Equashield® Pro is designed to make adoption of robotics in the IV room simple and affordable regardless of hospital size. It is easy to fit into hospital pharmacies and comparable in size to a standard Biological Safety Cabinet.

• Hazardous Drug Protection with use of Equashield’s leading Closed System Transfer Device tested for Leak Free connection and Air Tight closeness
• High Throughput to meet your compounding needs during peak time, enabling you to optimize patient care without sacrificing scarce resources
• Medication Error Protection with use of Equashield’s proprietary dose verification system to prevent wrong drug, wrong dose and labeling errors during compounding
• Small Footprint to fit into existing pharmacy space. Equashield Pro is comparable to the size of a standard Biological Safety Cabinet
• Highly Versatile to produce a wide range of patient specific dose with syringes, IV bags and other finished dose forms
• Cost Effective Solution to fit into any pharmacy budget. Additional cost avoidance from expensive renovation costs and expensive maintenance

​A Progressive Choice in Automated Hazardous Drug Compounding:

• Protection from Hazardous Drugs via the use of Clinically Proven CSTD System
• Highest Throughput in the Industry when preparing Patient Specific Doses by leveraging Equashield CSTD System
• Protection from Medication Errors during Compounding via the use of dose verification system

REDUCE YOUR  EXPOSURE RISK BY USING A CLINICALLY TESTED EQUASHIELD CSTD

When it comes to using a Closed System Transfer Device, there shouldn’t be any uncertainty on the level of safety
it offers. Either a CSTD is safe to use or it is not. Equashield helps eliminate grey areas and uncertainty by relying on
peer-reviewed or independent studies to test the system’s safety and efficacy. It starts with preventing surface
contamination, preventing plunger rod contamination, while adhering to NIOSH’s definition of ‘closed’ with proven data on leak-free disconnects and vapor containment. All while preventing microbial ingress and eliminating cumbersome workflows, making Equashield a TRULY CLOSED system.

At EQUASHIELD, we believe that Medical Devices should be held to the same standards as drugs. Our products are clinically evaluated and bound by peer reviewed or independent data on safety and efficacy:

1. Surface Contamination Reduction: 100% Reduction in Surface Contamination; Verified by Peer Reviewed Study, Performed At The Cleveland Clinic
2. Plunger Rod Contamination: ZERO contamination on Equashield Plunger Rods; Peer Reviewed Study, Performed At The Karmanos Cancer Institute
3. Leak Proof DIsconnects -ZERO leaks observed when tested with 5-FU; Peer Reviewed Study, Performed At The University of North Carolina
4. Airtight Containment - Complete Containment of IPA Vapors per 2015 NIOSH Protocol; Peer Reviewed Study, Performed At The University of North Carolina
5. Efficient to Use: Deemed Most Efficient System Tested By A Third Party With Least Number of Steps, Least Packages to Open and Requiring The Least Time To Prepare A Dose - Multi Location Study performed in Nebraska
6. Microbial Ingreass Prevention: Microbial Ingress Studies independently tested at Nelson Labs with use cases at Moutn Sinai Hospital and Sunnybrook Cancer Center.